期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | PAIN MEDICINE LetPub Score 6.4
50 ratings
Rate
Reputation 7.5 Influence 5.1 Speed 8.5 | ||||||||||||||||||||
期刊簡稱 | PAIN MED | ||||||||||||||||||||
ISSN | 1526-2375 | ||||||||||||||||||||
E-ISSN | 1526-4637 | ||||||||||||||||||||
h-index | 85 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 3.40%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://academic.oup.com/painmedicine | ||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/pme | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | VICER Publishing | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||
創刊年 | 2000 | ||||||||||||||||||||
每年文章數 | 107每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 18.46% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1526-2375%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 3 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 75% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[PAIN MEDICINE] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:42:01 評論於 Research subjects/experimental conditions/some kind of experimental treatment/experimental conclusions and other elements(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 08:13:57 評論於 Title: Guidelines for Controlling Title Length in SCI Papers(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 20:24:01 評論於 What should be paid attention to in the title of an article?(0) 讚! | Oswald Edie |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 14:02:39 評論於 Please translate the following passage into English and Japanese, and title the translations with ":" and ":". What points should the article title include?(0) 讚! | Darlene Pepys |
作者: Ula Clara 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-12 10:01:43 評論於 No page charges. I have not chosen open access(0) 讚! | Ula Clara |
作者: 长安诗岚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-12-25 18:14:28 評論於 The review process took a long time, the reviewers were very thorough, and I had to follow up twice in the middle. After 5 months, my paper was rejected. Despite the rejection, the reviewers provided detailed feedback(0) 讚! | 长安诗岚 |
作者: moonala 領域: 医学 審稿時間: 5.0 month(s) 結果: 拒稿 撰寫評論 |
2019-12-25 15:35:19 評論於 The review cycle was long, and the reviewers were more careful. I urged twice in the middle and it was rejected in 5 months. It was rejected, but they gave quite detailed comments. (0) 讚! | moonala |
作者: 一条小芷雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-13 14:25:45 評論於 What should I do after receiving it? I didn't receive any email about paying the page charges(0) 讚! | 一条小芷雪 |
作者: 一条小芷雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-12 21:17:32 評論於 When can I expect to receive the page fee notification after acceptance?(0) 讚! | 一条小芷雪 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 23:47:08 評論於 We can only hope for next year, after all, no need to worry as the overall trend is upward. Even if it rises only a little in a year, it will accumulate over time(0) 讚! | 凌霄高洁 |
作者: Ula Clara 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-06-24 23:40:10 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: Just submitted a paper, the review speed was 3 months, accepted after major revision once and minor revision once(0) 讚! | Ula Clara |
作者: Ula Clara 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-06-24 17:02:01 評論於 Just submitted an article, it took 3 months for the review process, and after one major revision and one minor revision, it got accepted(0) 讚! | Ula Clara |
作者: 雁荷酱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-07-17 20:53:13 評論於 Review speed: 3.0 | Submission acceptance rate: 75.0 Experience sharing: Just submitted a paper, the review speed is very slow, minor revisions were accepted after 2 times, but had to wait a long time each time. If you are in a hurry, it's better not to submit to this journal. The paper submitted in July 2014 was not officially published online until July 2015, a whole year(0) 讚! | 雁荷酱 |
作者: 乙酉大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-10-22 18:44:14 評論於 Review speed: 3.0 | Submission acceptance rate: 75.0 Experience sharing: Published a study on ERP processing in chronic pain. The first review took 3 months, with 2 major revisions and 1 minor revision. Recently submitted another paper, which took almost 4 months for the first review. After making revisions as suggested, it was resubmitted. The ease of publication is considered average. The expert reviews were very detailed(0) 讚! | 乙酉大叔 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-03-21 09:30:12 評論於 It has been over three months and it is still under review; the review process is too slow(0) 讚! | 凌霄高洁 |
作者: 长拳湘君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-12-22 09:11:45 評論於 Is it really suitable for Chinese people to invest? Experienced seniors, please share your insights(0) 讚! | 长拳湘君 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-05-26 20:31:57 評論於 The review process is too slow(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us